A petcare genetics company that builds early detection health risk tests and offers the world’s first at-home genetic testing platform for cats.
In 2022, Basepaws was acquired by Zoetis Inc.
By clicking “accept” or continuing to surf this site’s pages you understand that GingerBread Capital may collect information that has been provided by you.